Objective To investigate the clinical characteristics of pain in the early stage after three types of breast plastic

surgery， and to provide basis for optimizing the pain management plan. Methods From November 2021 to August 2022，

72patients who underwent breast augmentation， mammaplasty and breast suspension were included. The pain level （digital pain score， revised facial expression pain assessment method）， site， concomitant symptoms and medication were collected on the 1st，2nd and 3rd day after surgery， and the clinical characteristics of pain were analyzed. Results The pain level showed a

downward trend 1-3 days after operation. Patients who underwent breast augmentation had the highest pain levels， and

sustained moderate pain levels. The pain sites were mainly under the armpit （68.60%） and above the breast （49%）

. The pain sites after breast reduction surgery and breast suspension surgery were mainly at the lower edge of the breast （33.30%）， areola （33.30%）， and lateral breast （26.70%） . The incidence of bilateral breast pain in partial locations was inconsistent. Most patients had no other symptoms. 58.33% of patients used one drug for analgesia on the first day after operation， 37.5% of patients used two or more drugs for analgesia on the second day after operation， and 76.39% did not use drugs on the third day after operation. Conclusion The early pain of patients after breast augmentation deserves attention. The location of pain is mainly related to incision， drainage retention， prosthesis implantation and hematoma. When assessing pain， medical staff should pay attention to the regional characteristics of bilateral breast pain， identify the cause of pain， and detect and prevent hematoma as soon as possible. The choice of analgesics should avoid the overlapping use of drugs with the same mechanism， implement multimodal analgesia， combine non-drug intervention， and jointly manage pain and adverse drug reactions.

Breast plastic surgery, Breast augmentation, Breast reduction, Breast mastopexy, Pain